This test is most useful if any of these apply to you.
If grass season leaves you sneezing, rubbing your eyes, or coughing, this result can help identify a possible trigger. A positive result means antibodies in your blood recognize proteins or other structures in bromegrass pollen. Whether that recognition causes your symptoms depends on your exposure and symptom history.
Some people have these antibodies without seasonal symptoms. And because several grasses share similar pollen proteins, a positive brome result may reflect sensitization that began with another grass.
This test uses pollen from smooth brome, Bromus inermis. It is a cool-season grass grown for hay and pasture. The test is a quantitative serum immunoassay that measures IgE binding to bromegrass pollen extract. Results are reported in kUA/L, the laboratory unit for allergen-specific IgE.
IgE is a class of antibody involved in immediate allergic reactions. Some IgE attaches to mast cells in tissues and basophils in blood. These immune cells release chemicals involved in allergic reactions. When an allergen links neighboring IgE molecules on a cell, it can trigger the release of histamine and other substances that cause itching, sneezing, swelling, and airway symptoms.
The serum result measures circulating antibodies. It does not directly measure IgE attached to cells in your nose or lungs, or how strongly those cells respond when you encounter pollen.
Being sensitized means you have an immune response to an allergen, shown by specific IgE or an appropriate skin test. Being allergic means exposure to that allergen causes symptoms.
A positive result becomes more informative when symptoms coincide with local grass pollination. In many temperate regions, that is late spring and early summer, though timing varies by location and grass species. Without matching symptoms, the result establishes sensitization but cannot establish hay fever.
Even antibodies to major grass proteins can occur without symptoms. In one study comparing people with grass allergy and symptom-free controls, some controls had serum IgE to timothy and its main allergen. Their antibody patterns did not reliably distinguish symptomatic allergy from symptom-free sensitization.
Brome, timothy, and ryegrass belong to the Pooideae grass subfamily. Their pollen contains related proteins, so antibodies formed against one grass often bind to others. Laboratory studies that included brome found substantial cross-reactivity with other northern grasses.
This overlap helps explain a positive result, but it does not identify which grass originally sensitized you or which species you encountered. Bermuda and Bahia grasses have different allergen patterns, so local vegetation matters.
Most studies of grass allergy have measured serum IgE to timothy pollen or individual timothy proteins. Those are related but different measurements from bromegrass-specific IgE. They help explain grass allergy, but their numerical results and predictions cannot be transferred directly to your brome result.
Cross-reactivity also extends beyond grasses. Cross-reactive carbohydrate determinants, or CCDs, are sugar structures shared by many plant allergens. IgE against them can produce positive extract tests that have little clinical relevance. Profilin is a protein found in many pollens and plant foods. IgE to profilin can also explain multiple positive tests, though it can contribute to symptoms, including reactions to raw produce.
In a study of 547 people with pollen allergy in Beijing, many had positive timothy or Bermuda extract tests while relatively few recognized the major timothy proteins Phl p 1 and Phl p 5. Other tests pointed to extensive cross-reactivity. This was a regional study of timothy and Bermuda testing, so its findings do not establish how often a brome result is clinically relevant elsewhere.
Grass-specific IgE is useful when investigating seasonal allergic rhinitis. This is the medical term for hay fever. Sensitization sometimes appears before symptoms, but it can also remain symptom-free.
A birth cohort followed 820 children and measured serum IgE to timothy grass. Among the children whose sequence of sensitization and symptom onset could be assessed, about 46% had detectable sensitization at least a year before hay fever began. Antibody levels and the number of grass proteins recognized tended to increase as the disease developed.
In that cohort, 68% of children sensitized at age 3 developed grass-pollen hay fever by age 12. This shows that early sensitization can carry information about later risk. It does not establish the same probability for an adult, for a bromegrass result, or for a child from a different population. The study also did not show that screening symptom-free children or repeatedly measuring their IgE improves health outcomes.
Grass pollen can trigger asthma in people who are allergic to it. In a study of 73 people with allergic rhinitis and no previously diagnosed asthma who underwent an inhaled-allergen challenge, grass-specific serum IgE was the best single predictor of an early airway response among the measures studied. This was controlled challenge testing with grass allergens, not validation of bromegrass IgE as a standalone asthma test.
In a separate study of 1,120 children with grass-related hay fever, sensitization to the timothy protein Phl p 7 was uncommon and associated with asthma. It did not establish a reliable way to predict asthma or hay fever severity in an individual. A bromegrass result alone cannot diagnose asthma.
Grass sensitization can contribute to positive food tests in people who tolerate the foods. In a study that measured timothy sensitization, 65 grass-allergic adults tolerated cereals and peanut during supervised food challenges. Yet 38% had a positive result to at least one of those foods on one serum IgE testing platform. The proportion differed with the testing method.
Profilin sensitization can also accompany pollen-food allergy syndrome. This causes symptoms such as an itchy mouth after certain raw fruits or vegetables. The timothy component Phl p 12 detects IgE to profilin, but a positive brome extract result cannot establish that this is the reason for your food symptoms.
A higher result does not reliably predict a worse pollen season. In 78 grass-allergic people tested every two weeks across two seasons, pre-season serum IgE did not predict symptom severity, and changes in IgE did not closely track symptoms.
Blood and local tissue responses can also differ. In a small study of grass-allergic people with rhinitis, with or without asthma, grass-specific IgE in nasal samples rose during pollen exposure while serum levels did not rise significantly. Nasal IgE is a different measurement from this serum test.
In the study of 1,120 children, recognizing more timothy proteins was associated with higher total IgE and more pollen sensitizations, but not greater clinical severity. Your symptoms, sleep disruption, breathing, and medicine use remain more useful measures of how much allergy is affecting you.
Repeated measurements can show changes in circulating sensitization, but exposure, treatment, and assay differences can all influence the pattern. A rising result does not by itself establish worsening allergy, and a falling result does not prove that you have become tolerant. There is no validated bromegrass IgE target for judging treatment success.
Evidence-backed interventions that affect your Bromegrass IgE level
Bromegrass IgE is best interpreted alongside these tests.
Bromegrass IgE is included in these pre-built panels.
See exactly which airborne triggers your body reacts to, so your sneezing, congestion, and wheezing finally have names.
See a wide map of the foods and airborne triggers your immune system reacts to, so you can stop guessing what sets off your symptoms.
80 biomarkers